Pharmaceutical Technology

MARCH 15, 2023

Novo Nordisk has announced plans to reduce the US wholesale acquisition cost (WAC), also known as the list price, of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes. Novo Nordisk also has various long-standing US affordability offerings for eligible people who are living with diabetes.

Insulin 147

Insulin Production Branding Marketing 147

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 6, 2023

US pharmaceutical giant Eli Lilly announced Wednesday it would cut the cost of its insulin by 70 percent, with President Joe Biden calling on others to follow suit to tackle soaring drug prices.

Insulin 196

Insulin Drugs Manufacturing Clinical Trials 196

BioSpace

NOVEMBER 8, 2023

Citing manufacturing concerns and formulary losses, Novo Nordisk will discontinue its long-acting insulin Levemir by the end of next year amid strong pressure from U.S. lawmakers to lower insulin prices.

Insulin 119

Insulin Manufacturing 119

Pharmaceutical Technology

OCTOBER 12, 2022

Novo Nordisk has recently completed its six-part ONWARDS Phase III trial, as ONWARDS 5 reached its primary endpoint with Icodec demonstrating non-inferiority in reducing hemoglobin A1C (HbA1c) in patients with type 2 diabetes (T2D) at week 52 in comparison to once-daily basal insulin analogs. Patients had an overall baseline HbA1c of 8.9%

Insulin 182

Insulin FDA Approval Clinical Trials Clinical Trials 182

Bio Pharma Dive

MARCH 3, 2022

The nonprofit group announced ambitious plans to begin offering insulin at prices no higher than $30 per vial by early 2024.

Insulin 296

Insulin Drugs 296

Pharmaceutical Technology

SEPTEMBER 21, 2023

The licence grants Meitheal marketing rights for insulin aspart, lispro, and glargine following FDA approval.

Insulin 147

Insulin FDA Approval Marketing 147

Pharmaceutical Technology

MAY 17, 2023

It is no exaggeration to say that the world changed in the early 80s when insulin was expressed synthetically in microorganisms for the first time. This breakthrough led to a recombinant (biosynthetic) and thereby safer therapy for diabetes than the animal-sourced insulin which had been used since 1922.

Insulin 130

Insulin Gene Therapy Contamination Manufacturing 130

Bio Pharma Dive

JANUARY 13, 2023

The state filed suit Thursday against pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx, alleging they worked with drugmakers to drive up the price of insulin.

Insulin 143

Insulin Pharmacy 143

Fierce Pharma

SEPTEMBER 19, 2023

Novo Nordisk, following a similar move by its diabetes rival Eli Lilly, is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medi | Novo Nordisk is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medicine.

Insulin 114

Insulin Medicine 114

Pharmaceutical Technology

APRIL 14, 2023

Among several growth-promoting supplements added to the cell culture media formulations, insulin is one of the most common. Recombinant insulin is used as a supplement in the upstream manufacturing of a range of biologic drugs, including recombinant proteins, such as monoclonal antibodies, viral vectors, and viruses.

Insulin 130

Insulin Antibody Protein Vaccination 130

World of DTC Marketing

NOVEMBER 23, 2021

President Biden is set to address the cost of insulin but what about the costs of obesity which are in the billions? The post Insulin costs ignore the root cause of diabetes. Although not everyone with type 2 diabetes is overweight, obesity and an inactive lifestyle are two of the most common causes of type 2 diabetes.

Insulin 231

Insulin 231

Pharmaceutical Technology

JANUARY 10, 2023

In addition, market growth will be driven by dapagliflozin (Farxiga) in the SGLT-2I space, and novel GLP-1/GIP Mounjaro (tirzepatide), biosimilar/interchangeable insulins such as insulin lispro and insulin glargine (Basaglar), and the launch of once-weekly insulins icodec and Icosema, forecast for 2024 launch.

Insulin 130

Insulin Marketing Drugs Compliance 130

pharmaphorum

JANUARY 13, 2023

The ‘big three’ insulin producers Novo Nordisk, Eli Lilly, and Sanofi are being sued by the state of California for allegedly working together to set artificially inflated prices for their products. The suit follows legal action over insulin pricing taken by other states, including Arkansas , Kansas, Mississippi, and Minnesota.

Insulin 105

Insulin Drugs Manufacturing Pharmacy 105

pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 130

Insulin Drugs Hormones Pharmacy 130

Fierce Pharma

AUGUST 17, 2023

million settlement that would get Eli Lilly out of hot water over claims it jacked up the price of its lucrative insulin product Humalog. | million settlement unless it’s altered to make sure states can still file their own insulin pricing lawsuits. Nine states are saying not so fast to a proposed $13.5

Insulin 98

Insulin Production 98

NPR Health - Shots

MARCH 19, 2023

Under the $50 million deal, the state is partnering with drugmaker Civica to start making the new generic insulin later this year, Gov. Gavin Newsom said. Image credit: Damian Dovarganes/AP)

Insulin 145

Insulin 145

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 9, 2022

The most effective way for people with diabetes to deliver insulin is also incredibly intrusive. Millions around the world must inject the crucial hormone underneath their skin several times a day to keep their glucose levels in balance.

Insulin 187

Insulin Hormones Scientist Clinical Trials 187

Medical Xpress

APRIL 21, 2023

Just over a century has passed since the discovery of insulin, a time period during which the therapeutic powers of the hormone have broadened and refined. Insulin is an essential treatment for type 1 diabetes and often for type 2 diabetes, as well. million Americans use insulin, according to the American Diabetes Association.

Insulin 105

Insulin Hormones 105

Bio Pharma Dive

FEBRUARY 8, 2023

In a State of the Union address, Biden threatened to veto any efforts to repeal the legislation and chastised drugmakers for the current costs of insulin.

Insulin 143

Insulin Drugs 143

XTalks

NOVEMBER 15, 2022

In Lilly’s case, the fake account claimed the company was giving out free insulin. A fraudulent Eli Lilly account with the username @EliLillyandCo tweeted a message on November 10 that said: “We are excited to announce insulin is free now.”. On average, it is estimated that insulin costs about $98.70 percent, or by $16.08

Insulin 97

Insulin Sales Branding Life Science 97

XTalks

JULY 3, 2023

The treatment is derived from deceased donor pancreatic cells and is indicated for patients who are unable to achieve average blood glucose levels (glycated hemoglobin) with daily insulin injections or with continuous infusion through a pump because of repeated episodes of severe hypoglycemia (low blood sugar).

Insulin 98

Insulin Gene Therapy Gene Drugs 98

Medical Xpress

DECEMBER 12, 2022

WEHI researchers in Melbourne have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect? The findings provide important insights for the future development of an oral insulin pill.

Insulin 105

Insulin Research Development 105

Drug Channels

SEPTEMBER 15, 2023

Nicole summarizes MMIT’s research on payers’ views of two crucial market changes: (1) the Inflation Reduction Act of 2022’s requirement to cap insulin prices at $35 for Medicare beneficiaries, and (2) manufacturers’ reduction in list prices for certain insulin products.

Insulin 71

Insulin Drugs Manufacturing Research 71

STAT News

AUGUST 7, 2022

WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on Sunday, and now only Medicare patients will see relief at the pharmacy counter. Back in November, the party had grand ambitions of capping insulin costs at $35 per month for all patients with insurance.

Insulin 111

Insulin Pharmacy Packaging Packaging 111

STAT News

APRIL 21, 2023

WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.)

Insulin 98

Insulin Pharmacy Packaging Packaging 98

Medical Xpress

MAY 18, 2023

Louis have uncovered at least one reason insulin-secreting cells made from stem cells in the lab don't work as well as natural cells. The discovery could help speed progress toward making insulin-secreting cells—called islet beta cells—more effective in the treatment of insulin-dependent type 1 diabetes.

Insulin 105

Insulin Research Medicine 105

pharmaphorum

AUGUST 22, 2023

Amazon Pharmacy rolls out insulin discount coupons Phil.Taylor Tue, 22/08/2023 - 08:55 Bookmark this

Insulin 98

Insulin Pharmacy 98

Pharmaceutical Technology

JUNE 30, 2023

(Glucagon + insulin human)is under clinical development by Abvance Therapeutics and currently in Phase I for Hypoglycemia.

Insulin 100

Insulin Clinical Development Development 100

pharmaphorum

NOVEMBER 11, 2022

In addition to the financial hit, the stunt has only served to draw attention to Lilly’s role in the insulin pricing crisis in the United States, where multiple patients have died because of rationing unaffordable insulin. That’s why other insulin stocks are falling too. Happy Disability Awareness Month.

Insulin 98

Insulin Branding Production Marketing 98

Fierce Pharma

AUGUST 31, 2023

They are pressing insulin manufacturers on their plans to cut prices. . | It was a year ago this month that President Joe Biden signed the Inflation Reduction Act. While the landmark bill introduces several pricing measures, Democrats on Capitol Hill are still pursuing ways to rein in the pharma industry.

Insulin 115

Insulin Manufacturing 115

STAT News

MARCH 1, 2023

Eli Lilly, one of the largest makers of insulin, said Wednesday it would make dramatic cuts to the prices of several of its older insulin products in an effort to lower costs for consumers whose insulin is not fully paid for by insurance. The moves come amid a public and political uproar over the price of insulin.

Insulin 98

Insulin Production 98

pharmaphorum

APRIL 29, 2022

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that. cases of hypoglycaemia per year with insulin icodec, versus 0.27 In absolute terms, there were 0.73 events for the once-daily drug.

Insulin 98

Insulin Drugs Trials Medicine 98

BioPharma Reporter

MAY 5, 2022

Oramed Pharmaceuticals announced this week that it has enrolled 100% of the patients in the worldâs first Phase 3 study of oral insulin under FDA approved protocols.

Insulin 128

Insulin Clinical Trials Clinical Trials FDA Approval 128

XTalks

OCTOBER 8, 2021

Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks. The medtech giant has also expanded another Class I recall of the retainer rings on its 600 series insulin pumps.

Insulin 128

Insulin Drugs Life Science Regulation 128

STAT News

JANUARY 20, 2023

In an attempt to tackle the root causes of inflated insulin prices, the state of California filed a lawsuit last week accusing drug manufacturers and pharmacy benefit managers of artificially and illegally jacking up the price of insulin. The sausage-making of how insulin is priced is not for the faint of heart.

Insulin 105

Insulin Pharmacy Drugs Medicine 105

Medical Xpress

MARCH 18, 2023

In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly's move.

Insulin 104

Insulin 104

STAT News

MARCH 14, 2023

list prices for several insulin products by up to 75%, the latest big drugmaker to take such a step in response to a years-long outcry over the cost of the diabetes treatments. The company plans to cut the list price of its NovoLog insulin by 75%, and the prices for Novolin and Levemir by 65% starting in January 2024.

Insulin 98

Insulin Branding Production Drugs 98